Skip to content
Tuesday, 17 November 2026
Inspire.News

Unveiling truth, one story at a time

Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in Revenue

Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in Revenue
Image: The Motley Fool

J&J's quarterly sales have climbed with few setbacks, while Pfizer's have swung between $13.7 billion and $17.8 billion over eight quarters.

Full story

Continue reading this story on The Motley Fool, the publisher that reported it.

Read the full story at The Motley Fool ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from Business

See all